![[4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF](/docs/US/2019-04-11/US20190106393A1/abs.jpg.600x600.jpg)
- 专利标题： [4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF
-
申请号： US16210163申请日： 2018-12-05
-
公开(公告)号： US20190106393A1公开(公告)日： 2019-04-11
- 发明人: Kenji KAWASHIMA , Yusuke YAMAZAKI , Shinji TAKAOKA , Daisuke SHII , Tomoko ODA , Takahiro MATSUYAMA
- 申请人： SANTEN PHARMACEUTICAL CO., LTD.
- 申请人地址： JP Osaka
- 专利权人： SANTEN PHARMACEUTICAL CO., LTD.
- 当前专利权人： SANTEN PHARMACEUTICAL CO., LTD.
- 当前专利权人地址： JP Osaka
- 优先权： JP2015-166247 20150825
- 主分类号： C07D241/44
- IPC分类号： C07D241/44 ; C07F9/6509 ; A61P29/00 ; A61P27/02 ; C07D403/12 ; A61K31/675 ; A61K31/5377 ; A61K31/498
![[4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF](/abs-image/US/2019/04/11/US20190106393A1/abs.jpg.150x150.jpg)
摘要：
The present invention relates to defined quinoxalin-2-one compounds or a pharmaceutically acceptable salt or a hydrate or a solvate thereof. The compounds, salts or hydrates have a glucocorticoid receptor agonist activity, and are useful as a medicine, in particular as a prophylactic or therapeutic agent for a glucocorticoid receptor related disease.
公开/授权文献
信息查询
